drugset / Trial / NCT00249769

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

NCT00249769

RandomizedParallel-groupOpen-labelPrevention

Summary

This study will determine whether it is safe and effective to administer Japanese encephalitis (JE) live attenuated SA 14-14-2 vaccine at the same time as measles vaccine. If it is found to be safe, it will pave the way for use in routine vaccination programs. The hypothesis is that children who receive JE live attenuated SA 14-14-2 vaccine and measles vaccine at the same time are protected against these diseases at the same level as those who receive the vaccines at different intervals.

Timeline

Start
2005-11-21
Primary completion
2006-05-30
Completion
2006-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Live Japanese encephalitis vaccine SA 14-14-2 Vaccine 0.5 ml Subcutaneous
Subject Measles vaccine Vaccine 0.5 ml Subcutaneous

Indications